We acquire, develop and market a portfolio of mature branded medicines globally

Download our factbook

What we do

Pill icon


We acquire “mature” (i.e. post-patent expiry), established branded prescription medicines from large cap and specialty pharma.

Beaker icon


We develop line extensions (new formulations or new markets) to the medicines we acquire. We also develop our own niche generic medicines in-house.

Suitcase icon


We currently own and market a portfolio of 17 medicines and operate in more than 130 markets globally.

How we do it

Team icon


Our dedicated team of regulatory, artwork, technical and project management experts has vast experience in transitioning medicines seamlessly into our manufacturing and distribution networks, and working with vendors to ensure there is no disruption in supply to wholesalers, hospitals, pharmacies and ultimately – and most importantly – patients.

Microscope icon

Product Development

Our chemists work with our regulatory, artwork and technical experts to make the most of the medicines we acquire, developing new formulations for new markets. They also work on developing and launching generic medicines for niche indications.

Line up icon

In Line

Once we have successfully transitioned an acquired medicine or launched a developed medicine, our In Line team takes over the life cycle management of the medicines, making sure we maintain the highest standard of ethical medical practice, manage our supply chain effectively and responsibly and deliver high-quality medicines to our patients.

Our key therapeutic areas


Women’s Health

Our key medicines include Bonviva®, Gynest® and Traxidot®.

Man holding wrist in pain

Neuro and Pain

Our key medicines include Anaprox®, Naprosyn®, Sinepin®, Toradol® and Welldorm®.

Woman making heart shape with hands on tummy


Our key medicines include Dipentum®.

Cancer cell


Our key medicines include Bondronat® and Kytril®.

Our markets and offices

We partner with distribution partners to offer as wide a market coverage as possible. Our network now covers over 130 markets. We have offices in Basildon, Copenhagen, Dubai, Sydney and Vadodara.

  • Our markets
  • Map pin icon Our offices
Map of Atnahs distribution territories

Our partnerships and memberships


Our specialty pharma subsidiary, Pharmanovia, focuses upon in-licensing, out-licensing and development of both medicines and medical devices in the Nordics and Europe. Learn more at www.pharmanovia.com.


We are proud to be a member of EMIG, the Ethical Medicines Industry Group. Learn more at emig.org.uk.

Looking to license or divest a medicine?

Or are you a CMO or distributor who wishes to partner with us?

Get in touch